Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Millionfool.comRelay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Millionfool.comThis clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
BioLife Solutions' CFO Sells 30,000 Sharesfool.comThis bioproduction tools provider for cell and gene therapy reported a notable insider sale.
BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimateschartmill.comBioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response.
BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concernschartmill.comBioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY.
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024investorplace.comBLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024investorplace.comBLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Earnings Scheduled For February 29, 2024benzinga.comCompanies Reporting Before The Bell • Frontline (
NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buyingbenzinga.comAlthough U.S. stocks closed mixed on Monday, there were a few notable insider trades.
Top 5 Health Care Stocks That Could Blast Off This Monthbenzinga.comThe most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
